儿科病毒性心肌炎:机制,实验模型和研究差距
Ivana Ling1, Rafael A Aponte Alburquerque1, Ashley L Steed2
1Department of Pediatrics, Washington University School of Medicine, St. Louis, MO, USA.
Pediatric research
|February 27, 2026
概括
儿科病毒性心肌炎是心脏炎症和突然死亡的原因,由于年龄特定的免疫反应,与成人形式不同. 了解这些差异需要以儿科为重点的模型来改善诊断和治疗.
科学领域:
- 儿科心脏病学 儿科心脏病学
- 免疫学 免疫学 免疫学
- 病毒学 病毒学
背景情况:
- 病毒性心肌炎是儿童心脏炎症,扩张性心肌病和心脏突然死亡的重要原因.
- 目前的机理学理解主要来自成人模型,造成了儿童疾病病原发生的知识差距.
- 免疫反应,病毒热带和临床结果的年龄特异性差异对于儿童来说至关重要,但研究不足.
研究的目的:
- 审查涉及小儿心肌炎的病毒病原体及其在急性和慢性心脏损伤中的作用.
- 分析儿科病毒性心肌炎的实验模型,考虑影响疾病严重程度和翻译相关性的因素.
- 突出特定年龄的脆弱性,心肌损伤的细胞/分子机制,以及向扩张性心肌病的进展.
主要方法:
- 文献综述专注于儿童群体中的病毒性心肌炎.
- 对实验性感染模型的分析,包括病毒物种,宿主菌株和给药途径.
- 检查心脏损伤和疾病进展的细胞和分子机制.
主要成果:
- 与成人相比,儿童病毒性心肌炎表现出不同的免疫反应,病毒热带和临床结果.
- 实验模型揭示了儿科免疫系统的脆弱性,改变了病毒的持久性,以及心肌损伤的特定机制.
- 鼠类模型和人类之间的心脏解剖学和生理学的差异限制了翻译相关性.
结论:
- 儿科病毒性心肌炎需要专门的研究模型来解释免疫力和病毒相互作用的发育差异.
- 了解特定年龄的机制对于开发有针对性的疗法来减少儿童的发病率和死亡率至关重要.
- 未来的研究应该优先考虑开发和验证儿科特定模型,以推进诊断和治疗策略.
更多相关视频
06:04Author Spotlight: Establishment and Confirmation of a Postnatal Right Ventricular Volume Overload Mouse Model
Published on: June 9, 2023
1.6K
09:01An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 10, 2013
8.4K
相关概念视频
Myocarditis III: Medical Management
266
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
266
Myocarditis I: Introduction
498
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
498
Myocarditis II: Clinical Features and Diagnostic Tests
385
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
385
Myocarditis IV: Nursing Management
299
Myocarditis is an inflammatory condition of the myocardium requiring meticulous nursing management for optimal patient outcomes. Effective management begins with a thorough assessment of the patient's medical history, paying close attention to past infections, autoimmune disorders, travel history, and exposure to toxins or drugs. Recent viral infections and systemic diseases are particularly relevant due to their potential role in triggering myocarditis.Physical Examination and MonitoringThe...
299
Cardiomyopathy I: Introduction and Classification
702
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
702
